Vesalius Longevity Labs Inc. (CSE:VLAB)
1.680
+0.060 (3.70%)
At close: Nov 20, 2026
Vesalius Longevity Labs Market Cap
Vesalius Longevity Labs has a market cap or net worth of CAD 179.79 million as of November 20, 2026. It is the 23,062nd most valuable company in the world and the 560th biggest in Canada.
Market Cap
179.79M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#560 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since November 13, 2026, Vesalius Longevity Labs's market cap has increased from 179.48M to 179.79M, an increase of 0.18%. That is a compound annual growth rate of 9.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 179.79M | 3.70% |
| Nov 19, 2026 | 173.37M | 8.00% |
| Nov 18, 2026 | 160.53M | - |
| Nov 17, 2026 | 160.53M | 6.14% |
| Nov 16, 2026 | 151.24M | -15.73% |
| Nov 13, 2026 | 179.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Canopy Growth | 311.16M |
| Cresco Labs | 252.25M |
| BioSyent | 202.20M |
| Cannara Biotech | 201.38M |
| Medexus Pharmaceuticals | 188.68M |
| TerrAscend | 169.91M |
| Cardiol Therapeutics | 158.88M |
| Organigram Global | 136.78M |